Search
for

    Learn

    5 / 801 results

    Research

    5 / 1000+ results
      Navigating Rhupus Complexity

      research Navigating Rhupus Complexity

      January 2024 in “Ankara City Hospital Medical Journal”
      Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.
      Contents

      research Contents

      March 2014 in “Pediatric Clinics of North America”
      The document discusses how to identify and manage common skin conditions in children.

    Community Join

    5 / 1000+ results

      community Treating my DUPA via controlling inflammation

      in Treatment  5 upvotes 2 years ago
      The user has DUPA and suspects autoimmune activity as a cause. They have tried various treatments including finasteride, minoxidil, dutasteride, pyrilutamide, estrogel, hydrocortisone, and clobetasol, and are now seeking a long-term immunosuppressant.

      community DUPA, Non Responders and Connective Tissue Disorders

      in Research/Science  9 upvotes 11 months ago
      A 27-year-old male with diffuse hair loss, including the donor area, did not respond to finasteride, dutasteride, or minoxidil. He suspects his hair loss may be linked to a mild connective tissue disorder, possibly affecting the structural support of hair follicles, rather than being purely hormonal.

      community can someone help me identify these pls

      in Treatment 6 months ago
      The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.

      community My experience and a discourse on “DUPA”

      in Chat  46 upvotes 3 years ago
      How diffuse unpatterned alopecia (DUPA) is not an invitation to self-diagnose oneself with aggressive AGA and that seeking a specialized dermatologist may help people experiencing hair loss. Treatment options discussed include topical clobetasol propionate, oral minoxidil, and discontinuing finasteride.